Your browser doesn't support javascript.
loading
Liquid chromatographic method to follow-up ceftazidime and pyridine in portable elastomeric infusion pumps over 24 h.
Nguyen, Tam; Menten, Laurien; Spriet, Isabel; Quintens, Charlotte; Van Schepdael, Ann; Adams, Erwin.
Afiliação
  • Nguyen T; Department of Pharmaceutical and Pharmacological Sciences, Pharmaceutical Analysis, KU Leuven, Leuven, Belgium.
  • Menten L; Department of Pharmaceutical and Pharmacological Sciences, Pharmaceutical Analysis, KU Leuven, Leuven, Belgium.
  • Spriet I; Hospital Pharmacy Department, University Hospitals Leuven, Leuven, Belgium.
  • Quintens C; Hospital Pharmacy Department, University Hospitals Leuven, Leuven, Belgium.
  • Van Schepdael A; Department of Pharmaceutical and Pharmacological Sciences, Pharmaceutical Analysis, KU Leuven, Leuven, Belgium.
  • Adams E; Department of Pharmaceutical and Pharmacological Sciences, Pharmaceutical Analysis, KU Leuven, Leuven, Belgium.
Electrophoresis ; 43(9-10): 970-977, 2022 05.
Article em En | MEDLINE | ID: mdl-34780670
ABSTRACT
Portable infusion pumps are an interesting solution to continue outpatient parenteral antimicrobial therapy (OPAT) at the patient's home. However, the use of ceftazidime for such applications is challenging in view of its relatively poor stability in solution. In this study, elastomeric infusion pumps with 6 or 7 g of ceftazidime were deflated over 24 h in an oven at 33°C while ceftazidime and its degradation product, pyridine, were regularly monitored. Hereto, a fast and sensitive liquid chromatographic (LC) method has been developed using a Kinetex® C18 (150 × 3 mm, 2.6 µm) column with gradient elution. Ammonium formate 20 mM and acetonitrile (ACN) were mixed in a ratio of 982 v/v for mobile phase A and 8515 v/v for mobile phase B. Both were adjusted to pH 4.5 with formic acid. The flow rate was set at 0.4 mL/min. The solution with a starting dose of 6 g ceftazidime was found to be degraded 10% after an average of 19 h 11 min so that an administration of 6 g to the patient was not reached. For the solution with a starting dose of 7 g of ceftazidime, 10% degradation was observed after an average of 18 h 42 min. However, by starting from a higher dose, an average of 6.56 g of ceftazidime could be administered over 24 h. In addition, 1.0% of pyridine versus ceftazidime pentahydrate with sodium carbonate (=mixture for injection) was formed over 24 h.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bombas de Infusão / Ceftazidima Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bombas de Infusão / Ceftazidima Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article